IMPORTANCE Women are underrepresented in medical leadership positions; however, representation of women among academic oncology leadership is unknown. OBJECTIVES To evaluate representation of women overall and in leadership positions in academic medical oncology (MO), radiation oncology (RO), and surgical oncology (SO) programs and to examine the association of women leadership with overall faculty representation of women per program. DESIGN, SETTING, AND PARTICIPANTS In this cross-sectional study, MO, RO, and SO training program websites were queried from October 2018 through June 2019. All faculty from 265 of 273 accredited MO, RO, and SO training programs (97.1%) were included. EXPOSURE Gender. MAIN OUTCOMES AND MEASURES Observed proportions of women in leadership positions compared with the expected proportion of overall women faculty in MO, RO, and SO were assessed. Rates of representation of women across each MO, RO, and SO program's faculty based on the presence or absence of a woman in a leadership position were compared. RESULTS Of 6030 total faculty, only 2164 (35.9%) were women. Total representation of women among MO, RO, and SO faculty was 37.1% (1563 of 4215), 30.7% (389 of 1269), and 38.8% (212 of 546), respectively. Women composed only 21.7% (30 of 138), 11.7% (11 of 94), and 3.8% (1 of 26) of MO, RO, and SO chair positions, respectively. The observed proportion of women in chair positions
Introduction
Gender diversification of a physician workforce currently predominantly composed of men in the United States is an ongoing goal. 1 While some progress has been made, with the number of women enrolling in US medical schools exceeding the number of men for the first time, 2 women remain underrepresented in academic medicine. 3 Academic oncology also struggles with gender diversity in its workforce. For example, representation of women among trainees lags behind their counterparts who are men in both medical oncology (MO) and radiation oncology (RO), though this gender gap appears to be improving in MO. 4 As women constitute half of the US population, and cancer is the second leading cause of death for men and women, promoting a more gender-balanced workforce more representative of its patient population is critical.
Cross-sectional studies also demonstrate that women are underrepresented in key leadership positions, 5 which has been recently acknowledged by the World Health Organization. 6 At this time, the level of women faculty representation in academic oncology, particularly in leadership positions, is unknown. Therefore, this study evaluates representation of women in academic MO, RO, and surgical oncology (SO) departmental leadership positions. Furthermore, we examine the association of having a woman in a leadership position with overall rates of women faculty representation.
Methods
The Accreditation Council for Graduate Medical Education (ACGME) public program search website 7 was queried to identify MO ("hematology and medical oncology"), RO ("radiation oncology"), and Gender was first determined using a combination of first name review, pronoun descriptors, and images on publicly available websites. 8, 9 We then used a validated software tool that is designed to identify gender of individuals on the basis of their names, Gender-API, for each academic staff member in our study database to confirm our findings and clarify when corroborating profile information was not available. 10 This analysis was deemed exempt from Rush University Medical Center institutional review board approval given the use of publicly available data. This study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline for cross-sectional studies.
Statistical Analysis
The χ 2 goodness-of-fit test was applied to a 1-way frequency table to examine whether the observed proportion of women in leadership positions deviated significantly from the expected proportion based on the actual proportion of overall women faculty in MO, RO, and SO. A subset analysis focusing only on chair positions was also performed. Results from this 1-tailed test were considered statistically significant at P < .05.
Two-sample t tests were used to compare rates of women faculty representation across each program based on the presence or absence of a woman in a leadership position for MO, RO, and SO; results were considered statistically significant at a 2-tailed P < .05. (Figure) .
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The observed proportion of women in leadership positions overall was significantly lower than the expected proportion of women in leadership positions for RO (17.4% vs 30.7%; P < .001) and SO (11.1% vs 38.8%; P = .001), but not for MO (31.4% vs 37.1%; P = .06). On subset analysis, the observed proportion of women in chair positions deviated significantly from the expected value for RO (11.7% vs 30.7%; P < .001), SO (3.8% vs 38.8%; P < .001), and MO (21.7% vs 37.1%; P < .001) ( 
Discussion
In this study of gender representation in academic oncology, we found that women composed a minority of MO (37.1%), RO (30.7%), and SO (38.8%) faculty. Underrepresentation of women was particularly pronounced at the leadership level, with only 31.4%, 17.4%, and 11.1% of program director and chair positions in MO, RO, and SO, respectively, occupied by a woman. When restricting for only the chair position, representation of women was even lower at 21.7%, 11.7%, and 3.8% in MO, RO, and SO, respectively. We also tested the hypothesis that individual departments that had at least 1 woman in a leadership position would be associated with a higher proportion of overall women faculty, and this proved to be true for MO and RO, but not SO.
To our knowledge, this is the first study to comprehensively evaluate representation of women in leadership positions of academic MO, RO, and SO programs. Gender equality is one of the most important measures of health and health inequalities in our time. 11 Gender equality in science, medicine, and global health also has the potential to lead to substantial health, social, and economic gains. There is also evidence, primarily from the business world, that gender-diverse workplaces have improved productivity, innovation, decision-making, and employee retention and satisfaction. 12 Gender-diverse institutions are more likely to outperform those that are not gender diverse. 13 Any organization that is not gender diverse is thus failing to access and leverage talent.
Overcoming the gender discrepancy specifically in academic oncology leadership may have a sustained and meaningful impact by increasing role models who can inspire graduating residents to pursue academic positions. Radiation oncology residents who are women are more likely to prefer having a mentor of the same gender, to prefer seeing equal numbers of men and women faculty, and to select residency programs based on gender ratios compared with their counterparts who are men. 14 Similar feelings likely persist when choosing a job following training. Indeed, our study shows that MO and RO departments with women in leadership positions were associated with a significantly higher ratio of women faculty than programs without at least 1 woman in a leadership position.
Interestingly, SO demonstrated the highest rate of overall women faculty, but the lowest rates of women in leadership both overall and when restricted to the chair position, relative to MO and RO.
Unlike MO and RO, there was no association between having a woman chair with higher rates of total women faculty, although this is most likely due to low power. Similar low and disproportionate rates of women chairs are seen in other academic surgical specialties, including neurosurgery, 15 otolaryngology, 16 and plastic surgery. 17 These findings deserve more exploration.
